PISANU, AUGUSTA
 Distribuzione geografica
Continente #
NA - Nord America 243
EU - Europa 136
AS - Asia 87
SA - Sud America 4
OC - Oceania 1
Totale 471
Nazione #
US - Stati Uniti d'America 243
SG - Singapore 76
IT - Italia 68
NL - Olanda 54
CN - Cina 3
PL - Polonia 3
AZ - Azerbaigian 2
DE - Germania 2
EE - Estonia 2
RU - Federazione Russa 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
HK - Hong Kong 1
IN - India 1
KG - Kirghizistan 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 471
Città #
Santa Clara 190
Cagliari 40
Singapore 38
Rome 10
Los Angeles 5
Cicciano 3
Ploaghe 3
Warsaw 3
Ashburn 2
Baku 2
Bologna 2
Boston 2
Casandrino 2
Council Bluffs 2
Bishkek 1
Buenos Aires 1
Buffalo 1
Campo Grande 1
Cochabamba 1
Florence 1
Helsinki 1
Hong Kong 1
Indore 1
Lima region 1
Lisbon 1
Melbourne 1
Moscow 1
Newark 1
Phoenix 1
Prague 1
Reston 1
Riyadh 1
Sargodha 1
Sassari 1
Seattle 1
Tallinn 1
Tashkent 1
Vienna 1
Zurich 1
Totale 329
Nome #
Behavioral characterization of co-exposure to cannabinoids and hormonal contraceptives in female rats 39
Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2(WD40) Genetic Model of Parkinson's Disease. 38
Modeling Parkinson's disease neuropathology and symptoms by intranigral inoculation of preformed human ?-synuclein oligomers 31
Communal nesting differentially attenuates the impact of pre-weaning social isolation on behavior in male and female rats during adolescence and adulthood 30
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 29
Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences 23
Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study 21
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent 19
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 19
Early life social experiences and dysregulation of the brain reward system: age- and sex-dependent interactions 17
Adolescent cannabis exposure increases heroin reinforcement in rats genetically vulnerable to addiction 17
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 17
Hormonal contraceptives and reward in female rats 16
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders 15
Metabolomics Fingerprint Induced by the Intranigral Inoculation of Exogenous Human Alpha-Synuclein Oligomers in a Rat Model of Parkinson's Disease 15
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa 15
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 14
Social enrichment during early life attenuates specific behavioral alterations induced by early life stress in an age- and sex-dependent manner 13
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence 13
Impact of repeated exposure to hormonal contraceptives during adolescence on cannabinoid-induced behavior in female rats 12
Impairment of acquisition of intravenous cocaine self-administration by RNA-interference of dopamine D1-receptors in the nucleus accumbens shell 12
In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors 12
Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function 11
Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species 10
Differential effects of intravenous R,S-(+/-)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell and core 10
Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli. 10
Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: A confocal laser scanning microscopy study 9
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 9
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by mu opioid and D-1 dopamine receptors 8
ROSIGLITAZONE DECREASES PEROXISOME PROLIFERATOR RECEPTOR-GAMMA LEVELS IN MICROGLIA AND INHIBITS TNF-ALPHA PRODUCTION: NEW EVIDENCES ON NEUROPROTECTION IN A PROGRESSIVE PARKINSON'S DISEASE MODEL 7
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? 7
Modulating Microglia Activity with PPAR-gamma Agonists: A Promising Therapy for Parkinson's Disease? 7
Dynamic changes in pro-and anti-inflammatory cytokines in microglia after PPAR-g agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. 7
Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli 7
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease 7
Totale 546
Categoria #
all - tutte 1.855
article - articoli 1.633
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20249 0 0 0 0 0 0 0 0 0 3 3 3
2024/2025537 0 3 50 28 188 15 77 78 40 58 0 0
Totale 546